Valerio & Invus
- Biotech or pharma, animal health
Valerio Therapeutics is developing the next generation of precision-guided therapeutics through a differentiated, fully synthetic V-body platform—a new class of conjugatable single-domain antibodies (sdAbs of 15KDa)—engineered for enhanced tissue penetration, specificity, and therapeutic versatility
.
🔍 Unmet Need & Opportunity
Most therapeutic modalities today face major delivery limitations, leading to poor tissue penetration, off-target effects, and suboptimal efficacy—especially in solid tumors and complex indications like autoimmune or rare diseases
. Valerio addresses these challenges through targeted, modular, and rapidly engineerable V-bodies, enabling superior delivery and payload functionality across multiple administration routes.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}